Gravie adds healthcare executive Eric Murphy to its board as it lines up fresh backing led by General Atlantic

Gravie, a health benefits company focused on how employers and employees access and pay for healthcare, said it has appointed Eric Murphy, a veteran healthcare executive and former Optum leader, to its board of directors. The announcement also comes with news of a new funding round led by General Atlantic, a healthcare and growth-focused investment firm that often backs companies aiming to reshape delivery and financing in the sector.

Murphy’s role adds to Gravie’s leadership bench with experience in health services and payer-related operations. The company did not describe in detail, in the announcement associated with the report, what specific initiatives he will oversee on the board, or how his prior work at Optum will map to Gravie’s near-term product roadmap.

Gravie positions itself as a different way for workers and employers to navigate healthcare costs and decision-making, emphasizing benefits design that can reduce friction at the point of care. The approach targets a long-running problem in the U.S. benefits market, where employees face complex coverage rules, varying out-of-pocket costs, and administrative hurdles that can influence whether care is delayed or forgone.

For employers, these issues can translate into higher volatility in healthcare spend and increased operational burden. Many large companies have experimented with benefit redesigns, including consumer-directed health plans and new vendor platforms, but adoption has often been constrained by uncertainty over patient outcomes, predictability of costs, and administrative complexity. Gravie’s pitch is aimed at addressing the experience and cost components together, rather than treating coverage changes as a standalone exercise.

The reported funding round led by General Atlantic indicates continued investor interest in healthcare infrastructure that sits between traditional coverage and the care journey. However, the announcement did not provide, in the information available from the reported item, the size of the round, the valuation implied by the financing, or whether it includes any additional investors beyond General Atlantic.

In addition to the board appointment and the financing, Gravie’s next steps are likely to depend on how it scales its benefit offering across employer segments. For startups in this space, capital typically supports expansion of technology and provider enablement, along with underwriting or risk processes that allow the company to manage variability in healthcare utilization.

Even with fresh capital, the company’s ability to execute will be measured by specifics that were not included in the report, such as how Gravie’s model performs on measured outcomes (including cost and access), how it integrates with employer HR and benefits workflows, and how quickly it can onboard new customers without degrading service.

Investors will also watch for how Gravie navigates regulatory and contracting realities in the U.S. health benefits ecosystem. The report did not outline whether the board and financing are tied to new program design changes, new state or federal regulatory initiatives, or expanded partnerships with health systems, payers, or technology vendors. Those details remain unclear from the public announcement item.